PHI LIFE SCIENCES, LLC
CHARLESTON, SC

Phi Life Sciences, LLC is a forward-thinking Molecular Diagnostic and Laboratory Service company founded on April 29, 2016. Headquartered in the SCRA MUSC Innovation Center at 645 Meeting Street, Suite 3, Charleston, SC 29403, its mission centers around reducing disease mortality and minimizing adverse drug reactions through affordable, top-tier screening and diagnostic technologies. Dedicated to advancing healthcare standards, Phi Life Sciences champions early disease detection and precision medicine management. The pioneering team behind the company employs a 'bench to bedside' philosophy, offering advanced diagnostic tools that foster effective treatment at the outset of disease progression, thereby improving patient health outcomes. With over 40 years combined experience in molecular diagnostics, the experts at Phi Life Sciences have made strides in clinical research programs compliant with CMS and FDA regulations. The team is also skilled in developing both proprietary and licensed technologies while providing educational outreach about molecular diagnostic media. Their clinical support services assist healthcare professionals in interpreting complex test results to enhance patient care. Though operating from South Carolina, the company is organized as a Florida entity under the type FORL since January 11, 2017. It is registered in Duval County, SC, and initially with FEI Number: 81-2542375 in Jacksonville, FL. Phi Life Sciences offers sophisticated diagnostic solutions such as Genotyping, Gene Expression, Next Generation Sequencing, accompanied by comprehensive study design support services that comply with CLIA, CAP, GLP, and ICH E15 standards. Interested parties can reach them at (888) 576-5445 for more information. The company experienced a significant milestone on November 1, 2019, when it was reinstated. They have planned to submit an annual report in the year 2024 by April 22, 2024. Leading the charge are key officers Sawan Hurst, Robert Barfield, and Dorothy Fitzsimmons.